NuVessl

NuVessl is a food & beverage company in Casablanca, Canada, founded in 2017. It has raised $945K across 2 rounds, most recently a $200K Seed in March 2020.

Nanotechnology encapsulation for better ingredient delivery

Headquarters
Casablanca
Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$945K
Last Round
$200K SeedMar 2020
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

NuVessl is a nanotechnology company that develops a patented Nano-Lipidic Particle (NLP) encapsulation platform to carry active ingredients across pharmaceuticals, consumer goods, agriculture, and animal health. Their technology manufactures 1nm+ all-natural liposomes that accept single or multiple water-, fat-, or bi-soluble active ingredients, enabling custom release profiles (rapid, delayed, timed, sustained), flavour masking, and increased ingredient lifespan. NuVessl licenses its technology and forms partnerships while also building proprietary brands, targeting over $300 billion in addressable segment sales.

Summary

It lists 1–10 employees. It has raised $945K in total across 2 rounds, most recently a $200K Seed round in Mar 2020. Investors include Plug and Play.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundMar 2020
$200K

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NuVessl on Indexed.vc
<a href="https://indexed.vc/companies/nuvessl"><img src="https://indexed.vc/api/badge/company/nuvessl" alt="NuVessl on Indexed.vc" width="260" height="76" /></a>